chr2-135907405-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001349.4(DARS1):​c.1417T>C​(p.Leu473Leu) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00798 in 1,608,994 control chromosomes in the GnomAD database, including 270 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 90 hom., cov: 31)
Exomes 𝑓: 0.0064 ( 180 hom. )

Consequence

DARS1
NM_001349.4 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 2.60

Publications

5 publications found
Variant links:
Genes affected
DARS1 (HGNC:2678): (aspartyl-tRNA synthetase 1) This gene encodes a member of a multienzyme complex that functions in mediating the attachment of amino acids to their cognate tRNAs. The encoded protein ligates L-aspartate to tRNA(Asp). Mutations in this gene have been found in patients showing hypomyelination with brainstem and spinal cord involvement and leg spasticity. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2014]
DARS1 Gene-Disease associations (from GenCC):
  • hypomyelination with brain stem and spinal cord involvement and leg spasticity
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 2-135907405-A-G is Benign according to our data. Variant chr2-135907405-A-G is described in ClinVar as [Benign]. Clinvar id is 380521.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.6 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0641 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DARS1NM_001349.4 linkc.1417T>C p.Leu473Leu splice_region_variant, synonymous_variant Exon 16 of 16 ENST00000264161.9 NP_001340.2 P14868-1A0A140VJW5
DARS1NM_001293312.1 linkc.1117T>C p.Leu373Leu splice_region_variant, synonymous_variant Exon 15 of 15 NP_001280241.1 P14868-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DARS1ENST00000264161.9 linkc.1417T>C p.Leu473Leu splice_region_variant, synonymous_variant Exon 16 of 16 1 NM_001349.4 ENSP00000264161.4 P14868-1
DARS1ENST00000422708.3 linkc.478T>C p.Leu160Leu splice_region_variant, synonymous_variant Exon 6 of 6 2 ENSP00000387508.1 H7BZ35
DARS1ENST00000478212.5 linkn.311T>C splice_region_variant, non_coding_transcript_exon_variant Exon 3 of 3 2
DARS1ENST00000489964.5 linkn.666T>C splice_region_variant, non_coding_transcript_exon_variant Exon 5 of 5 2

Frequencies

GnomAD3 genomes
AF:
0.0224
AC:
3408
AN:
152064
Hom.:
83
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0654
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0106
Gnomad ASJ
AF:
0.0228
Gnomad EAS
AF:
0.00865
Gnomad SAS
AF:
0.0333
Gnomad FIN
AF:
0.00104
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00304
Gnomad OTH
AF:
0.0167
GnomAD2 exomes
AF:
0.0120
AC:
2960
AN:
246774
AF XY:
0.0120
show subpopulations
Gnomad AFR exome
AF:
0.0660
Gnomad AMR exome
AF:
0.00444
Gnomad ASJ exome
AF:
0.0250
Gnomad EAS exome
AF:
0.00561
Gnomad FIN exome
AF:
0.00167
Gnomad NFE exome
AF:
0.00350
Gnomad OTH exome
AF:
0.0119
GnomAD4 exome
AF:
0.00644
AC:
9388
AN:
1456812
Hom.:
180
Cov.:
29
AF XY:
0.00701
AC XY:
5083
AN XY:
725006
show subpopulations
African (AFR)
AF:
0.0678
AC:
2252
AN:
33196
American (AMR)
AF:
0.00516
AC:
228
AN:
44226
Ashkenazi Jewish (ASJ)
AF:
0.0254
AC:
660
AN:
26024
East Asian (EAS)
AF:
0.0151
AC:
596
AN:
39508
South Asian (SAS)
AF:
0.0281
AC:
2414
AN:
85842
European-Finnish (FIN)
AF:
0.00148
AC:
79
AN:
53338
Middle Eastern (MID)
AF:
0.0162
AC:
93
AN:
5758
European-Non Finnish (NFE)
AF:
0.00213
AC:
2367
AN:
1108744
Other (OTH)
AF:
0.0116
AC:
699
AN:
60176
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
395
790
1186
1581
1976
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0227
AC:
3451
AN:
152182
Hom.:
90
Cov.:
31
AF XY:
0.0231
AC XY:
1718
AN XY:
74406
show subpopulations
African (AFR)
AF:
0.0662
AC:
2747
AN:
41508
American (AMR)
AF:
0.0106
AC:
162
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.0228
AC:
79
AN:
3472
East Asian (EAS)
AF:
0.00867
AC:
45
AN:
5188
South Asian (SAS)
AF:
0.0336
AC:
162
AN:
4824
European-Finnish (FIN)
AF:
0.00104
AC:
11
AN:
10588
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00304
AC:
207
AN:
68000
Other (OTH)
AF:
0.0166
AC:
35
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
163
327
490
654
817
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0126
Hom.:
17
Bravo
AF:
0.0247
Asia WGS
AF:
0.0330
AC:
115
AN:
3478
EpiCase
AF:
0.00371
EpiControl
AF:
0.00464

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Feb 15, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
5.6
DANN
Benign
0.48
PhyloP100
2.6
Mutation Taster
=97/3
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs76296777; hg19: chr2-136664975; API